COVID-19 vaccine drive via video conferencing at 10.30 am on Saturday.India approved the emergency authorisation of two vaccines against novel coronavirus — Covaxin by Bharat Biotech and Covishield by Serum Institute of India.
Earlier, Britain and Argentina had approved the emergency marker use of coronavirus vaccine developed by the University of Oxford and AstraZeneca.
Serum Institute of India, the world's largest vaccine manufacturer by volume, joined hands with British-Swedish drugmaker to produce 1 billion doses of its COVID-19 vaccine.
The local version of Oxford-AstraZeneca COVID-19 vaccine will be known as Covishield.How does this vaccine work?The 'virus-vectored' vaccine uses a weakened version of a chimpanzee common coldvirus that.